LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 79.34 | 84.90 | 172 | 9051 | 0.0190 | 0.1105 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 79.34 | 84.90 | 1564 | 9051 | 0.1728 | 0.5411 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 79.34 | 84.90 | 112 | 9051 | 0.0124 | 0.0420 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 79.34 | 84.90 | 1642 | 9051 | 0.1814 | 0.5523 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.05 | 84.90 | 173 | 8863 | 0.0195 | 0.1120 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.05 | 84.90 | 1620 | 8863 | 0.1828 | 0.5523 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.05 | 84.90 | 96 | 8863 | 0.0108 | 0.0185 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.05 | 84.90 | 1664 | 8863 | 0.1877 | 0.5585 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.75 | 84.90 | 174 | 8621 | 0.0202 | 0.1137 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.75 | 84.90 | 1649 | 8621 | 0.1913 | 0.5605 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.75 | 84.90 | 106 | 8621 | 0.0123 | 0.0339 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.75 | 84.90 | 1668 | 8621 | 0.1935 | 0.5632 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.45 | 84.90 | 174 | 8254 | 0.0211 | 0.1148 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.45 | 84.90 | 1684 | 8254 | 0.2040 | 0.5721 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.45 | 84.90 | 108 | 8254 | 0.0131 | 0.0371 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.45 | 84.90 | 1694 | 8254 | 0.2052 | 0.5735 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 86.16 | 84.90 | 191 | 8141 | 0.0235 | 0.1311 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 86.16 | 84.90 | 1715 | 8141 | 0.2106 | 0.5786 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 86.16 | 84.90 | 101 | 8141 | 0.0124 | 0.0267 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 86.16 | 84.90 | 1722 | 8141 | 0.2115 | 0.5796 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 84.90 | 156 | 7680 | 0.0203 | 0.0981 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 84.90 | 1718 | 7680 | 0.2237 | 0.5884 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 84.90 | 107 | 7680 | 0.0139 | 0.0362 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 84.90 | 1758 | 7680 | 0.2289 | 0.5941 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 89.57 | 84.90 | 172 | 7494 | 0.0230 | 0.1154 | MN20160318_Q02 | C15 |